Literature DB >> 11328762

Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.

K Maebashi1, M Niimi, M Kudoh, F J Fischer, K Makimura, K Niimi, R J Piper, K Uchida, M Arisawa, R D Cannon, H Yamaguchi.   

Abstract

Four Candida albicans isolates, TIMM 3163, TIMM 3164, TIMM 3165 and TIMM 3166, with reduced fluconazole susceptibility were obtained from three AIDS patients in Japan, and the mechanisms of their drug resistance were studied. All isolates showed lower levels of intracellular accumulation of fluconazole than ATCC 10231, a susceptible control strain of C. albicans. Increased amounts of CDR1 and CDR2 mRNA encoding putative ATP binding cassette (ABC) transporters were associated with the azole resistance of all TIMM isolates, apart from TIMM 3164. In addition, increased Cdr1p levels were immunodetected in the cell membrane fractions of all the TIMM strains except for TIMM 3164. Gene amplification was not responsible for CDR1 overexpression and there were no significant differences in the mRNA levels of CDR3 or CDR4 (ABC transporters) in the azole-susceptible and -resistant cells. CaMDR1 (a major facilitator superfamily) gene expression was not observed in any of the resistant isolates or the control strain. These results suggest that energy-dependent drug efflux associated with increased expression of CDR1 and CDR2 is involved in the fluconazole resistance mechanisms in two of the four isolates, TIMM 3165 and TIMM 3166. TIMM 3164 demonstrated energy-dependent drug efflux without overexpression of CDR1-4 or CaMDR1, indicating that some other pump may be operating. Despite showing low levels of drug efflux and overexpression of CDR1 and CDR2, efflux in TIMM 3163 was not energy dependent, suggesting that the expressed Cdr1p non-functional Cdr1p and that other resistance mechanisms may operate in this strain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328762     DOI: 10.1093/jac/47.5.527

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.

Authors:  Preeti Pancholi; Steven Park; David Perlin; Christine Kubin; Phyllis Della-Latta
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

Review 2.  Targeting efflux pumps to overcome antifungal drug resistance.

Authors:  Ann R Holmes; Tony S Cardno; J Jacob Strouse; Irena Ivnitski-Steele; Mikhail V Keniya; Kurt Lackovic; Brian C Monk; Larry A Sklar; Richard D Cannon
Journal:  Future Med Chem       Date:  2016-07-27       Impact factor: 3.808

3.  Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.

Authors:  K Niimi; K Maki; F Ikeda; A R Holmes; E Lamping; M Niimi; B C Monk; R D Cannon
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a D-octapeptide derivative inhibitor.

Authors:  Kyoko Niimi; David R K Harding; Ann R Holmes; Erwin Lamping; Masakazu Niimi; Joel D A Tyndall; Richard D Cannon; Brian C Monk
Journal:  Mol Microbiol       Date:  2012-07-13       Impact factor: 3.501

5.  Molecular mechanisms of itraconazole resistance in Candida dubliniensis.

Authors:  Emmanuelle Pinjon; Gary P Moran; Colin J Jackson; Steven L Kelly; Dominique Sanglard; David C Coleman; Derek J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

6.  Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.

Authors:  Sarah Tsao; Fariba Rahkhoodaee; Martine Raymond
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

7.  Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors.

Authors:  Markus Niewerth; Donika Kunze; Michael Seibold; Martin Schaller; Hans Christian Korting; Bernhard Hube
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

Review 8.  Fungal PDR transporters: Phylogeny, topology, motifs and function.

Authors:  Erwin Lamping; Philippe V Baret; Ann R Holmes; Brian C Monk; Andre Goffeau; Richard D Cannon
Journal:  Fungal Genet Biol       Date:  2009-10-24       Impact factor: 3.495

Review 9.  Efflux-mediated antifungal drug resistance.

Authors:  Richard D Cannon; Erwin Lamping; Ann R Holmes; Kyoko Niimi; Philippe V Baret; Mikhail V Keniya; Koichi Tanabe; Masakazu Niimi; Andre Goffeau; Brian C Monk
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

10.  ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.

Authors:  Ann R Holmes; Ya-Hsun Lin; Kyoko Niimi; Erwin Lamping; Mikhail Keniya; Masakazu Niimi; Koichi Tanabe; Brian C Monk; Richard D Cannon
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.